PubMed Health⌕ Search

PubMed · 11147299

Regular form factor. A new concept and calculating method for quantitative form description.

Abstract

OBJECTIVE: To quantitatively describe the shape of two-dimensional particles based on combined consideration of area (A), circumference (C), and major and minor diameter (d1 and d2, respectively). STUDY DESIGN: A regular form factor (RFF), a new concept and calculating method for form description, was defined as the extent to which a structure differs from an ellipse or circle of which the major and minor diameters, respectively, are equal to the described structure. Based on the definition of RFF, formulae were deduced in accordance with mathematical principles. RESULTS: The deduced formulae were as follows: RFF = A [1.5(a + b) - square root of (a b)]/(a b C) and RFF = A [3 (d1 + d2) - 2 square root of (d1 d2)]/(d1 d2 C). In the formulae, a = d1/2, and b = d2/2. RFF = 1 for ellipses and circles, and < 1 for irregular particles. The more similar to an ellipse or circle, the closer to 1 is RFF. The more irregular the structures are, the smaller the values of RFF. An error analysis was also made, and a rectified formula for RFF was deduced. An example is given to show how to calculate RFF. A practical test of RFF was made in colorectal adenoma and adenocarcinoma in human material, and the results show that RFF of glands of colorectal adenoma and adenocarcinoma have significant differences between normal, adenoma and adenocarcinoma. CONCLUSION: RFF was compared with the parameter Form AR, and the results showed that RFF is more sensitive in describing the irregularity of a structure than Form AR. RFF is of practical significance for describing structures in human material.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Shen. 2000. Regular form factor. A new concept and calculating method for quantitative form description.. https://pubmed.ncbi.nlm.nih.gov/11147299/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[HER-2 diagnostics].

HER-2 (c-erbB2, neu) receptor is the molecular marker of ductal breast cancer although it is verexpressed in other adenocarcinoma as well (e.g.endometrial, colorectal and lung cancers). The increased receptor expression is most frequently (90-97%) due to gene amplification. Detection of the overexpression of HER-2 helps to determine prognosis, to predict chemoresistance and to select for Herceptin therapy. HER-2 overexpression can be estimated either by immunohistochemistry or by fluorescent in situ hybridisation (FISH). Standardization of the immunohistochemical HER-2 tests is the best in HercepTest DAKO), however, the frequent 2+level requires complementary FISH test to verify gene amplification. This combination is not necessary at low (0-1+) or high (3+) level of immunohistochemical reactions, because the correlation with gene amplification status is acceptably high. Recently several new anti-HER-2 antibodies have been introduced into HER-2 diagnostics in various countries. According to our experiences we recommend to combine rationally the immunohistochemistry and FISH techniques to determine the HER-2 status in breast cancer.

Adenocarcinoma↗